Guiying Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Circular RNAs in diseases 4
- Pluripotent Stem Cells Research 2
- RNA Interference and Gene Delivery 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 4
- Co-authors
- Fuller W. Bazer (1 shared paper)Greg A. Johnson (1 shared paper)Thomas E. Spencer (1 shared paper)Lisong Yang (2 shared papers)Manas K. Ray (1 shared paper)Milton J. Finegold (1 shared paper)Zhizhan Xu (3 shared papers)Jian-Gang Wang (1 shared paper)
- Journals
- Optik (2 papers)In Vitro Cellular & Developmental Biology - Animal (1 paper)Clinical & Translational Oncology (1 paper)Stem Cell Reports (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Guiying Wang
20 papers receiving 306 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 110
- Developmental Neuroscience 27
- Immunology 54
- Biophysics 13
- Molecular Biology 150
Countries citing papers authored by Guiying Wang
This map shows the geographic impact of Guiying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiying Wang more than expected).
Fields of papers citing papers by Guiying Wang
This network shows the impact of papers produced by Guiying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiying Wang. The network helps show where Guiying Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiying Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 48 | |
| 2 | 2000 | 43 | |
| 3 | Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. | 1997 | 36 |
| 4 | 2013 | 23 | |
| 5 | 2013 | 22 | |
| 6 | 2000 | 22 | |
| 7 | 2010 | 20 | |
| 8 | 2017 | 18 | |
| 9 | 2018 | 16 | |
| 10 | 2019 | 15 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 10 | |
| 13 | 2002 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2004 | 2 | |
| 20 | 2008 | 1 |
About Guiying Wang
Guiying Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Biophysics and Biomedical Engineering, having authored 20 papers that have together received 310 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Pluripotent Stem Cells Research (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer-related Molecular Pathways (2 papers), Advanced Fluorescence Microscopy Techniques (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (110 citations), Developmental Neuroscience (27 citations), Immunology (54 citations), Biophysics (13 citations) and Molecular Biology (150 citations). Guiying Wang has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Fuller W. Bazer, Greg A. Johnson, Thomas E. Spencer, Lisong Yang, Manas K. Ray, Milton J. Finegold, Zhizhan Xu, Jian-Gang Wang, Wenwen Jia and Susan Magdaleno. Their work appears in journals such as Optik, In Vitro Cellular & Developmental Biology - Animal, Clinical & Translational Oncology, Stem Cell Reports and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.